1. Home
  2. MBUU vs VNDA Comparison

MBUU vs VNDA Comparison

Compare MBUU & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Malibu Boats Inc.

MBUU

Malibu Boats Inc.

HOLD

Current Price

$26.05

Market Cap

560.3M

Sector

Industrials

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

N/A

Current Price

$6.65

Market Cap

474.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MBUU
VNDA
Founded
1982
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
560.3M
474.0M
IPO Year
2013
2005

Fundamental Metrics

Financial Performance
Metric
MBUU
VNDA
Price
$26.05
$6.65
Analyst Decision
Hold
Strong Buy
Analyst Count
8
5
Target Price
$32.43
$14.90
AVG Volume (30 Days)
309.3K
1.7M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
127.74
N/A
EPS
N/A
N/A
Revenue
$807,561,000.00
$216,105,000.00
Revenue This Year
$1.44
$21.35
Revenue Next Year
$10.67
$37.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.72
52 Week Low
$24.07
$3.81
52 Week High
$39.65
$9.91

Technical Indicators

Market Signals
Indicator
MBUU
VNDA
Relative Strength Index (RSI) 40.27 39.52
Support Level $24.43 $4.36
Resistance Level $34.66 $8.29
Average True Range (ATR) 0.97 0.48
MACD 0.24 -0.22
Stochastic Oscillator 41.30 7.29

Price Performance

Historical Comparison
MBUU
VNDA

About MBUU Malibu Boats Inc.

Malibu Boats is a designer and manufacturer of power boats in the United States. It is a market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a producer of sterndrive boats, in 2017, and Pursuit Boats, which makes high end offshore and outboard motorboats in 2018. In 2021, it purchased Maverick Boat Group, a seller of flat fishing boats, with exposure to bay, dual console, and center console boats. Malibu has also expanded into boat trailers and accessories, and in 2020, began producing its own engines for its performance sport boats.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: